Containing Or Obtained From Panax Or Acanthopanax (e.g., Ginseng, Etc.) Patents (Class 424/728)
-
Publication number: 20040076689Abstract: The present invention relates to an extract having healing activity on injuries, which is obtained by extracting Astragali Radix, Ginseng Radix, Carthami Flos, Angelicae Gigantis Radix, Cnidii Rhizoma, Rehmanniae Radix Preparata, Paeoniae Radix and Cinnamomi Cortex Spissus with water while heating, and a pharmaceutical composition for treating injuries, a health food for post-surgical recovery and an animal feed containing said extract as the active ingredient.Type: ApplicationFiled: August 18, 2003Publication date: April 22, 2004Inventor: Jong-soo Hong
-
Publication number: 20040076641Abstract: A dietary supplement for ingestion by humans is formulated to reduce blood pressure level, increase energy and promote general wellbeing. The supplement contains, in a tablet or capsule form, as active ingredients Spica Prunella flos, Chrysanthemi flos, Lonicera Japonica, Radix Notoginseng, Cleistocalyx Operculatis, Lentinus Edodes, and Sophora Japonica.Type: ApplicationFiled: October 14, 2003Publication date: April 22, 2004Inventor: Timothy Kershenstine
-
Publication number: 20040076684Abstract: A nutritional compositions for alleviating fatigue is produced by grinding essentially Panax ginseng, androgen-containing Cervus sika, vitamin A- and B-containing extract of fruit meat of Euphoria longana, Dioscorea batalus, and Acanthopanax senticosus into powder, and then mixing and formulating the resulting powders with gelatin and pure water into a formulation, wherein, in 350 mg of said nutritional composition, the effective amounts of each components is: Panax ginseng 105 mg, androgen extracted from Cervus sika 51 mg, Acanthopanax senticosus 15 mg, gelatin 86 mg, pure water 14 mg, and vitamin A and B extracted from fruit meat of Euphoria longana 24 mg each.Type: ApplicationFiled: October 18, 2002Publication date: April 22, 2004Inventor: Ching-Chi Lin
-
Publication number: 20040071794Abstract: The present invention is a method for enhancing the efficacy of an active ingredient in a human comprising: administering to said human a product comprising: a kavalactone component and an active ingredient, wherein said active ingredient is selected from the group consisting of a therapeutic, a pharmaceutical, a nutraceutical and a botanical, and wherein said kavalactone component comprises a methysticin component, a dihydromethysticin component, a desmethoxyyangonin component, a yangonin component, a dihydrokavain component, and a kavain component, and wherein said kavalactone component is between about 0.1% to about 75%, by mass, of said product.Type: ApplicationFiled: April 8, 2003Publication date: April 15, 2004Inventors: Robert Gow, John Pierce, Brian Pierce, William Birdsall
-
Publication number: 20040071795Abstract: The present invention provides an ATP synthesis activator which allows the promotion of ATP synthesis in the body and results in an increased ATP level in the body for a long period of time. The ATP synthesis activator comprises, as an active ingredient, a mixture of a plurality of herbs having an ion-exchange capacity. It may stimulate electron generation in the body and hence results in an improved ATP synthesis activity due to the generated electrons, because dietary fiber contained in the herbs has an ion-exchange capacity.Type: ApplicationFiled: August 1, 2003Publication date: April 15, 2004Inventor: JungMan Yoon
-
Publication number: 20040043054Abstract: This invention describes a method and composition to enhance the synthesis and release of the neurotransmitters by the oral administration of neurotransmitter precursors, along with natural plant substances that stimulate uptake of the neurotransmitters precursors, while adding natural plant substances that activate adenylate cyclase in order to avoid attenuation and prevent pharmacologic tolerance. The invention describes compositions for a medical foods that are designed to improve cognitive function, induced sleep, a improve Parasympathetic function, improve autonomic balance, increase nitric oxide production, reduce blood pressure, increase blood flow, and treat virus infections. The compositions include amino acids such as choline, herbs such ginkgo biloba, and other foods such as coca.Type: ApplicationFiled: August 27, 2002Publication date: March 4, 2004Inventors: William Shell, Elizabeth Charuvastra
-
Publication number: 20040043080Abstract: The present invention provides a pharmaceutical composition and a health food which can be ingested conveniently, and can effectively prevent or treat male sterility. The pharmaceutical composition and the health food comprise an oyster extract and a ginseng extract.Type: ApplicationFiled: August 7, 2003Publication date: March 4, 2004Inventors: Matsutaro Matsui, Motoshi Kurumiya
-
Publication number: 20040037788Abstract: A gum, lollipop and lozenge having at least two separate components, with at least one of such components containing amounts of herbal, medicinal and/or mineral elements or combinations thereof.Type: ApplicationFiled: August 21, 2003Publication date: February 26, 2004Inventor: Jack Barreca
-
Patent number: 6696094Abstract: The present invention provides a pharmaceutical composition for treating patients with HIV infection. The pharmaceutical composition is in the form of an intravenous injection solution and optionally capsules. The pharmaceutical composition contains fourteen (14) ingredients, i.e., diffuse hedyotis, bistort rhizome, giant knotweed rhizome, Asiatic moonseed rhizome, baical skullcap root, bovine biliary powder, milkvetch root, barbary wolfberry fruit, sanqi, figwort root, Chinese magnoliavine fruit, turmeric root-tuber, hawthorn fruit, and Chinese angelica.Type: GrantFiled: July 31, 2002Date of Patent: February 24, 2004Inventor: Tzu-Sheng Wu
-
Publication number: 20040033276Abstract: A composition for coating cereals comprising an extract of mulberry leaves(Mori Folium) or an extract of a herb mixture comprising mulberry leaves and a starch solution having a concentration ranging from 10 to 50 % (w/v), the extract:starch solution weight ratio being in the range of 21:1 to 21:10, wherein the herb mixture consists of mulberry leaves and a herb medicine selected from the group consisting of Panax Ginseng, Mori Fructus, Lycil Fructus and a mixture thereof.Type: ApplicationFiled: July 29, 2003Publication date: February 19, 2004Inventors: Jeong-Chan Ra, Kyung-Sun Kang, Jin-Hee Bae, Dow Kwon
-
Publication number: 20040023889Abstract: Food supplement compositions and their methods of use in increasing lean mass and/or muscle size and/or strength in individuals, particularly, athletes is described. The food supplements described comprise &agr; lipoic acid or a derivative thereof, and an amino acid. Other food supplements described comprise a substance which can enhance and/or mimic activity of &agr; lipoic acid, and a source of amino acid. The food supplement compositions described are suitable for supplementing the diet of an athlete and particularly for enhancing an athlete's muscle size and/or strength.Type: ApplicationFiled: April 15, 2003Publication date: February 5, 2004Inventors: Paul Gardiner, Derek Woodgate
-
Publication number: 20040009243Abstract: The present invention relates to a composition which contains as an active ingredient a ginsenoside glycoside (one or more component selected from the group consisting of ginsenoside Rg3, ginsenoside Rg5 and ginsenoside Rh2) or a ginseng extract in combination with a ginsenoside glycoside (one or more component selected from the group consisting of ginsenoside Rg3, ginsenoside Rg5 and ginsenoside Rh2), together with an adjuvant acceptable in the pharmaceutical or sitological field, and is formulated in the preparation form acceptable in the pharmaceutical or food purpose field by a method acceptable in the pharmaceutical or food chemistry. The composition of the present invention has a superior cancer-preventive effect on cancers occurring in individuals and populations having a high risk rate of cancer.Type: ApplicationFiled: July 8, 2003Publication date: January 15, 2004Inventors: Taik Koo Yun, Weon Seon Hong
-
Patent number: 6676977Abstract: Compositions and methods for reducing or eliminating the appearance of cellulite. The method involves administering to a patient in need of treatment therapeutically effective amounts of a sugar compound that is converted to a glycosaminoglycan in the patient in an amount sufficient to thicken the skin, a primary antioxidant component in an amount sufficient to substantially inhibit the formation of collagenase and elastase, at least one amino acid component in an amount sufficient to assist in the thickening of the skin, and at least one transition metal component in an amount effective to bind collagen and elastic fibers and thicken skin so as to reduce or eliminate the appearance of cellulite. A preferred method of treatment further includes administering the components above in conjunction with a vascular dilator to improve blood supply to the skin and/or a fat burner to reduce absorption or digestion of fat in the digestive tract or to prevent the production of fat.Type: GrantFiled: January 22, 2002Date of Patent: January 13, 2004Inventor: Howard Murad
-
Publication number: 20040005369Abstract: A method for processing biochemical fine powders of ginseng or the like to obtain effective ingredients, mainly including the steps of harvesting raw material, washing and dehydrating the same; forming the raw material into a mixture of liquid and paste by using millers, rollers, roller millers and/or kneaders; filtering the mixture of liquid and paste to form a suspension; and drying the suspension to form very fine powders which contain active cells and high quality ingredients of ginseng or the like. Furthermore, additional steps of sedimentation and separation after the filtering step; keeping the raw material fresh (e.g. vacuum forming or keeping it at low temperature) after dehydrating the same; sterilization (e.g. ultra-violet light, high temperature, gamma ray radiation, etc.) during or after the drying step; concentrating the suspension (e.g. sudden cooling or low temperature low pressure treatment) after the separation step; extraction; distillation; physical separation, and ionic exchange.Type: ApplicationFiled: April 21, 2003Publication date: January 8, 2004Inventors: William Chuang, King Chuang
-
Publication number: 20040001862Abstract: The present invention relates to herbal compositions and methods for regulating body weight, especially for promoting body weight loss, for maintaining or controlling body weight, reducing blood levels of circulating chemical fuels (e.g., glucose, carbohydrates, fatty acids, and cholesterol), facilitating or promoting metabolism, treating diabetes, treating body weight disorders, and the like.Type: ApplicationFiled: February 26, 2003Publication date: January 1, 2004Inventor: Rulin Xiu
-
Publication number: 20030232096Abstract: A fatigue recovery medicine for changing in hepatic mRNA levels of stress-related genes is disclosed. The fatigue recovery medicine for changing in hepatic mRNA levels of stress-related genes is composed of: astragali radix of 13.2% by weight, atractylodis rhizoma alba of 8.8% by weight, angelicae gigantis radix of 8.8% by weight, longanae arillus of 8.8% by weight, lycii folium of 8.8% by weight, cridii rhizoma of 6.7% by weight, hoellen of 4.4% by weight, glycyrrhizae radix of 4.4% by weight, carthami flos of 4.4% by weight, cervi parvum cornu of 4.4% by weight, crataegi fructus of 4.4% by weight, rehmanniae radix preparata of 4.4% by weight, saussureae radix of 4.4% by weight, amomi fructus of 4.4% by weight, polygony multiflori radix of 4.4% by weight, paeoniae radix alba of 4.4% by weight and ginseng radix of 4.4% by weight.Type: ApplicationFiled: August 22, 2002Publication date: December 18, 2003Inventor: Jun-Sik Shin
-
Patent number: 6660308Abstract: The invention is a beverage made of a fluid and a one time daily dosage amount in an ingestible amount for treating an inflammatory tissue or arthritic condition in a mammal involving tissue that is underperfused tissue, inflamed joints, and inflamed muscle, wherein said dosage is a rapid absorbing large amount made of a glucosamine sulfate, a glucosamine hydrochloride, and an n-acetyl glucosamine and combinations thereof, a chondroitin sulfate, a chondroitin hydrochloride and combinations thereof, a vasodialating sulfonate with at least one methyl group, and a buffer to reduce adverse symptoms from large amounts of glucosamine and chondroitin selected from the family of araliaceae and a B3 vitamin.Type: GrantFiled: September 11, 2002Date of Patent: December 9, 2003Inventors: Kenneth A. Martin, Teresa Leigh Barr
-
Publication number: 20030224071Abstract: The present invention relates to compositions and methods for managing connective tissue disorders in a patient, a sugar compound that is converted to a glycosaminoglycan, a primary antioxidant component, at least one amino acid component, at least one transition metal component, at least one moisturizing agent, at least one fatty acid. In a preferred embodiment, the composition for topical administration to the patient's skin further included hydrogen peroxide in an amount sufficient to cleanse the skin.Type: ApplicationFiled: December 11, 2002Publication date: December 4, 2003Inventor: Howard Murad
-
Publication number: 20030224062Abstract: The present invention provides a dietary or food supplement for healthy humans that includes a combination of 4-hydroxyisoleucine and creatine, or nutraceutically acceptable derivatives of these two compounds. The supplement may include additives such as carbohydrates or amino acids. The invention further includes a regimen for supplementing a healthy athlete's diet by administering on a regular basis to the athlete 4-hydroxyisoleucine and creatine, or nutraceutically acceptable derivatives of these two compounds. The invention also provides a method for enhancing the body's absorption and utilization of a nutrient, comprising administering 4-hydroxyisoleucine or a nutraceutically acceptable derivative thereof in combination with the nutrient.Type: ApplicationFiled: April 22, 2003Publication date: December 4, 2003Inventors: Peter J. Miller, Christine Steele, Kevin Kerr
-
Patent number: 6645533Abstract: An ATP synthesis activator is provided, which allows the promotion of ATP synthesis in the body and results in an increased ATP level in the body for a long period of time. The ATP synthesis activator comprises, as an active ingredient, a mixture of a plurality of herbs having an ion-exchange capacity. It may stimulate electron generation in the body and hence results in an improved ATP synthesis activity due to the generated electrons, because dietary fiber contained in the herbs has an ion-exchange capacity. Preferably, the herb mixture includes thyme, rosemary, turmeric, fennel, grape seeds, dandelion, and Acanthopanax senticosus. Also the composition is useful for treating immune deficiency diseases.Type: GrantFiled: December 7, 2001Date of Patent: November 11, 2003Inventor: JungMan Yoon
-
Publication number: 20030206978Abstract: A solid dosage form is provided which includes an active agent and silicified microcrystalline cellulose, the dosage form formed by a) combining a wetted active agent with dry silicified microcrystalline cellulose in a dryer to form agglomerated particles; and b) incorporating the agglomerated particles into the solid dosage form. In certain preferred embodiments, step b comprises combining said silicified microcrystalline cellulose, said active agent, and colloidal silicon dioxide in a dryer. Preferably, the dryer is a spray dryer, and, in certain embodiments, the active agent may be an herbal extract.Type: ApplicationFiled: September 27, 2002Publication date: November 6, 2003Inventors: Bob Sherwood, Joseph A. Zeleznik, David Schaible, Wilhelm Berkulin, Karl-Hans Theissing
-
Patent number: 6641846Abstract: The invention is related to a pharmaceutical composition with its main effects against Type I Allergy and the process thereof. The composition mainly comprises the following raw materials by weight ratio: 30˜60 parts of Fructus Jujubae, 12˜55 parts of Radix Astragali, 8˜15 parts of Radix glycyrrhizae, 6˜12 parts of Ramulus cinnamomi, 6˜12 parts of Ginger and 4˜8 parts of Green tea.Type: GrantFiled: January 16, 2001Date of Patent: November 4, 2003Assignee: Tianjin Yanling Health Food Co.Inventors: Zuoguang Zhang, Yanling Fu
-
Publication number: 20030203050Abstract: A process for preparing dry extracts from a liquid extract and at least one additional substance by a spray-drying process, characterized in that said at least one additional substance is added to the spray-drying process in a dry form during the spray-drying processes.Type: ApplicationFiled: September 27, 2002Publication date: October 30, 2003Inventors: Bob Sherwood, Joseph A. Zeleznik, David Schaible, Wilhelm Berkulin, Karl-Hans Theissing
-
Publication number: 20030203053Abstract: The invention provides methods and compositions for maintaining a state of wellness in a human by providing a dietary supplement comprising L-arginine, alone or in combination with ginseng and ginkgo biloba and/or additional nutritional supplements. The invention provides a unique blend of components that, in combination, synergistically bestow sexual wellness upon a human when taken regularly as a dietary supplement.Type: ApplicationFiled: April 7, 2003Publication date: October 30, 2003Inventors: Hank C.K. Wuh, Aileen S. Trant
-
Publication number: 20030194451Abstract: The present invention is related to a crude drug composition essentially comprising herbs of Sinapis Semen Alba, Ginseng Radix, Zingiberis Rhizoma Siccus, Amomi Fructus, Myristicae Semen, Saussureae Radix, Cyperi Rhizoma, Magnoliae Cortex, Arecae Semen, Crataegi Fructus, Atractylodes Rhizoma Alba, Agastachis Herba, Glycyrrhiza Radix and additionally comprising at least one herb selected from group consisting of Polygonati Rhizoma, Artemisiae Argyi Folium, Forsythiae Fructus, Caryophylli Flos, Raphani Semen, Menthae Herba according to the need for the prevention and treatment of gastrointestinal dyskinetic diseases and methods of using the above crude drug composition and pharmaceutical composition as prokinetic agent.Type: ApplicationFiled: April 11, 2003Publication date: October 16, 2003Applicant: Pangenomics Co., Ltd.Inventors: Byung Wook Cho, Mirim Jin, Hyung-Jin Jung, Sunyoung Kim
-
Publication number: 20030194435Abstract: The present invention relates to effervescent compositions containing active ingredients, in particular dry plant extracts, wherein the acid donor of the effervescent couple is constituted by a dried fruit juice with a natural acid pH, such as freeze-dried citrus fruit juice.Type: ApplicationFiled: March 31, 2003Publication date: October 16, 2003Applicant: ABOCA S.P.A.Inventor: Valentino Mercati
-
Patent number: 6632459Abstract: The present invention relates to a preparation for stimulating or enhancing an immune system comprising one or more agents that stimulate T-lymphocytes in vivo. Such a preparation can be sued in the prophylaxis and/or treatment of a medical condition. The invention further relates to a preparation for use in a pharmaceutical or food product and to a preparation for medical use.Type: GrantFiled: December 11, 2000Date of Patent: October 14, 2003Assignee: Nutricia N.V.Inventors: Yvo Maria Franciscus Graus, Hobbe Friso Smit, Albertus Dominicus Marcellinus Erasmus Osterhaus, Robert Johan Joseph Hageman
-
Publication number: 20030190378Abstract: The present invention relates to an extract of processed Panax genus plant, the preparation thereof and compositions containing the same having anticancer or anti-allergic activity. More particularly, the present invention relates to a processed ginseng product with enhanced pharmacological effects due to serial treatment i.e., acid-treatment or heat-treatment of a Panax genus plants and subsequent bio-converting treatment such as lactic fermenting and intestinal-bacterial fermenting process so as to make a ratio of ginsenoside (Rk2+Rh3+protopanaxadiol+20-dehydroprotopanaxadiol) to (Rg3+Rg5+Rk1) of above 0.1. The extract of processed Panax genus plant in the present invention has inhibitory effect for cancer or allergic diseases and it is useful in the prevention or treatment of cancer or allergic diseases.Type: ApplicationFiled: January 16, 2003Publication date: October 9, 2003Applicant: Ginseng Science Inc.Inventors: Dong-Hyun Kim, Eun-Ah Bae, Myung-Joo Han, Min-Kyung Choo, Eun-Kyung Park, Jeong-Hill Park
-
Publication number: 20030190377Abstract: The present invention relates to novel use of the extract of processed Panax genus having anti-Helicobacter pylori activity. More particularly, the present invention relates to a processed Panax genus extract with enhanced pharmacological effects due to subsequent treatment i.e., acid-treatment or heat-treatment of a Panax genus plants and bio-converting treatment such as lactic acid bacterial fermenting and intestinal bacterial fermenting process so as to make a ratio of ginsenoside (Rk2+Rh3+protopanaxadiol+20-dehydroprotopanaxadiol) to (Rg3+Rg5+Rk1) of above 0.1. The extract of processed Panax genus plant in the present invention has inhibitory effect for Helicobacter pylori bacteria and H+/K+-ATPase enzyme and, therefore, it is useful in the prevention or treatment of gastrointestinal diseases caused by abnormal proliferation of Helicobacter pylori such as gastritis, gastric ulcer, duodenal ulcer and gastric cancer.Type: ApplicationFiled: January 16, 2003Publication date: October 9, 2003Applicant: Ginseng Science Inc.Inventors: Dong-Hyun Kim, Eun-Ah Bae, Myung-Joo Han, Min-Kyung Choo, Eun-Kyung Park, Jeong-Hill Park
-
Patent number: 6630176Abstract: The present invention provides herbal compositions that can prevent or reduce the severity, intensity, or duration of allergic and/or asthmatic symptoms and/or can prevent or delay the development of an allergic or asthmatic response to an antigen. The compositions may optionally include one or more adjuvants, cytokines, encapsulating materials, or pharmaceutical carriers or excipients, and may be administered prior to, during, or after the development of allergic or asthmatic symptoms in sensitized individuals. Alternatively or additionally, the compositions may be administered prior to sensitization to a particular antigen; preferably substantially concurrently with exposure to the antigen.Type: GrantFiled: March 7, 2001Date of Patent: October 7, 2003Assignee: Mount Sinai School of Medicine of New York UniversityInventors: Xiu-Min Li, Hugh A. Sampson
-
Publication number: 20030185910Abstract: The present invention relates to a composition which contains as an active ingredient a ginsenoside glycoside (one or more component selected from the group consisting of ginsenoside Rg3, ginsenoside Rg5 and ginsenoside Rh2) or a ginseng extract in combination with a ginsenoside glycoside (one or more component selected from the group consisting of ginsenoside Rg3, ginsenoside Rg5 and ginsenoside Rh2), together with an adjuvant acceptable in the pharmaceutical or sitological field, and is formulated in the preparation form acceptable in the pharmaceutical or food purpose field by a method acceptable in the pharmaceutical or food chemistry. The composition of the present invention has a superior cancer-preventive effect on cancers occurring in individuals and populations having a high risk rate of cancer.Type: ApplicationFiled: February 8, 2002Publication date: October 2, 2003Inventors: Taik Koo Yun, Weon Seon Hong
-
Publication number: 20030180248Abstract: The present invention relates to a cosmetic composition containing the extract of mountain ginseng adventitious roots. The extract of mountain ginseng adventitious roots is prepared by extracting the natural mountain ginseng using ethanol. The cosmetic compositions containing the extract have good whitening effect.Type: ApplicationFiled: February 4, 2003Publication date: September 25, 2003Inventors: Min-Seok Joung, Bong-seok Seo, Jong-oan Choi, Yong-ho Joo
-
Publication number: 20030175315Abstract: Disclosed herein is nanoemulsion prepared by emulsifying main metabolites of ginseng saponin obtained by conversion of glucose, i.e. compound K (20-O-&bgr;-D-glucopyranosyl-20(S)-protopanaxadiol), ginsenoside F1 (20-O-&bgr;-D-glucopyranosyl-20(S)-protopanaxatriol) and compound Y (20-O-[&agr;-L-arabinopyranosyl(1→6)-&bgr;-D-glucopyranosyl]-20(S)-protopanaxadiol); and admixture thereof, in fine emulsion or liposome with dermotropic emulsifier by nano-emulsification; and having enhanced skin penetration, so to be effective in promoting proliferation of fibroblast and biosynthesis of collagen.Type: ApplicationFiled: January 3, 2003Publication date: September 18, 2003Inventors: Byung Hee Yoo, Byung Young Kang, Myeong Hoon Yeom, Dae Seok Sung, Sang Hoon Han, Han Kon Kim, Hee Kyung Ju
-
Publication number: 20030170322Abstract: Provided is a throat care agent which promotes the secretion of the saliva, promoting the secretion of a large amount of mucin which is a bactericidal component contained in the saliva, inhibiting the adhesion of pathogenic bacteria to the throat, and removing them from the throat to keep it refreshed. A throat care agent comprising a component promoting the secretion of the saliva.Type: ApplicationFiled: November 15, 2002Publication date: September 11, 2003Inventors: Shigeto Kayane, Tsutomu Isobe, Tadayuki Iwase, Yasuhiro Miura
-
Publication number: 20030157126Abstract: The present invention provides herbal compositions that can prevent or reduce the severity, intensity, or duration of allergic and/or asthmatic symptoms and/or can prevent or delay the development of an allergic or asthmatic response to an antigen. The compositions may optionally include one or more adjuvants, cytokines, encapsulating materials, or pharmaceutical carriers or excipients, and may be administered prior to, during, or after the development of allergic or asthmatic symptoms in sensitized individuals. Alternatively or additionally, the compositions may be administered prior to sensitization to a particular antigen; preferably substantially concurrently with exposure to the antigen.Type: ApplicationFiled: March 7, 2001Publication date: August 21, 2003Inventors: Xiu-Min Li, Hugh A. Sampson
-
Publication number: 20030152650Abstract: A pharmaceutical composition for the prevention and treatment of premature ejaculation and/or hypersensitivity of sexual stimulation is provided. The composition contains purified sumsoo extract and purified ginseng extract containing saponin as the main component, without other herbal essential oil components.Type: ApplicationFiled: December 23, 2002Publication date: August 14, 2003Inventors: Jin-ah Kang, Tae-Jin Ham, Hee-chol Kang, Hi-Jae Cho, Young-hoon Kim, Seong-hak Jeong
-
Publication number: 20030152544Abstract: The present invention comprises novel combinations of ginseng berry juice and extracts combined with other skin nutrients and moisturizers which may be used to soften and moisturize the skin while providing essential vitamins and nutrients to the skin in a natural way.Type: ApplicationFiled: November 26, 2002Publication date: August 14, 2003Inventor: Jau-Fei Chen
-
Publication number: 20030152651Abstract: This invention provides compositions comprising extracts of Radix Salviae Miltiorrhizae, Radix Notoginseng and Borneol. Said compositions comprise notoginsenoside R1 and ginsenoside Rg1 which are active components for therapeutic applications. This invention also provides a method of preparation of the said compositions and a method of identification and determination of the amount of individual effective components of said compositions. Finally, this invention provides various uses of the compositions.Type: ApplicationFiled: July 31, 2002Publication date: August 14, 2003Applicant: Tianjin Tasly Pharmaceutical Co., Ltd., ChinaInventors: Xijun Yan, Naifeng Wu, Zhixin Guo, Zhengliang Ye, Yan Liu
-
Publication number: 20030147969Abstract: The present invention provides a method for treating patients with liver diseases by co-administrating a pharmaceutical composition and lamivudine to the patients. The pharmaceutical composition is a herbal mixture which contains, as the core ingredients, the aqueous extracts of the entire plant of Herba Hedyotidis diffusae, the rhizome of Rhizoma Bistortae, the rhizome of Rhizoma Polygoni Cuspidati, and the ripe fruit of Fructus Schisandrae. The present invention also provides methods for preventing a relapse of hepatitis in patients after the lamivudine treatment has been discontinued and for suppressing the development of lamivudine drug resistance in patients by providing the lamivudine-treated patients with the pharmaceutical composition of the present invention.Type: ApplicationFiled: July 11, 2002Publication date: August 7, 2003Inventor: Tzu-Sheng Wu
-
Publication number: 20030143291Abstract: Herbal compositions and methods suitable for weight loss management and for treating diabetes are disclosed. The compositions comprise Ferula hermonis or an extract thereof, or Ferula hermonis with selected herbs, extracts thereof, and mixture thereof. The methods of reducing weight, and treating diabetes in patients involve oral administration of the compositions. The invention further relates to a method of extracting and standardizing Ferula hermonis extracts and tincture useful for human health.Type: ApplicationFiled: January 31, 2002Publication date: July 31, 2003Inventor: Yousry M.A. Naguib
-
Publication number: 20030143290Abstract: The present invention is related to pharmaceutical composition essentially comprising herbal extract of Chaenomelis Fructus, Achyranthis Radix, Acanthopanax, Phlomidis Radix, Gentianae Radix, Clematidis Radix, and additionally comprising herbal extract selected from group consisting of Angelicae Radix, Cnidii Rhizoma, Gastrodiae Rhizoma, Safflower, Cinnamomi Cortex, Job's tear, Aurantii nobilis Pericapium, Ledebouriellae Radix, Lonicera japonica, Akebiae caulis, Caragana chamlagu, Licorice root, Notopterygium incisum, Persicae semen, Eucommia ulmoides, Atractylodes Rhizoma, Torilis japonica according to the need for the prevention and treatment of arthritic diseases and methods of using the above extracts and composition as potent anti-inflammatory and anti-arthritic agents.Type: ApplicationFiled: January 16, 2003Publication date: July 31, 2003Applicant: Pangenomics Inc.Inventors: Byung-Wook Cho, Mirim Jin, Hyung-Jin Jung, Sung-Seup Shin, Sunyoung Kim, Hyang Jeon, Jin-Hwan Oh, Hae-Kwan Eo, Bongcheol Kim
-
Publication number: 20030143289Abstract: The present invention relates to herbal compositions and herbal extracts useful for treating cerebral vascular disease, including stroke, intracranial hemorrhage, intracranial infarction, and vascular dementia. The present invention can be used to reduce mortality rate and improve the quality of life of an individual after pathological injury that results in cerebrovascular and/or neuronal disorders. Further, the invention relates to the treatment of acute intracerebral hemorrhage by the novel herbal formulation PHY828 and provides methods of making PHY828 compositions.Type: ApplicationFiled: November 19, 2002Publication date: July 31, 2003Applicant: The Affiliated Hospital of Chengdu University of Traditional Chinese MedicineInventor: Shaohong Chen
-
Publication number: 20030138504Abstract: A method and composition for the treatment of diabetic neuropathy is disclosed. The composition comprises a cold compounded mixture of a compound that promotes synthesis of nerve growth factor, an aldose reductase inhibitor and an antioxidant formulated in a pharmaceutically acceptable carrier. It has been found that this combination of active agents provides significant, effective relief of the symptoms of diabetic neuropathy, as well as at least partial recovery of lost neurological function in some cases. In view of the consensus in the art that effective combinations of various active agents have not been demonstrated to be effective for the treatment of diabetic neuropathy, the present invention provides a surprising and unexpected effect. In addition, the topical compositions of the present invention, when used in effective amounts to treat diabetic neuropathy, do not exhibit the severe side effects of many prior art compositions proposed for treatment of this ailment.Type: ApplicationFiled: February 19, 2003Publication date: July 24, 2003Inventor: Richard Allen Rosenbloom
-
Patent number: 6596321Abstract: This invention relates to a pharmaceutical composition used for treating cardiovascular diseases and a method for preparing it. The pharmaceutical composition mainly contains polysacchrides, saponins and amino acids extracted from Radix ginseng, Radix ophiopogonis and Fructus schisandrae chinensis. The method of preparing it includes the following steps: Radix ginseng, Radix ophiopogonis and Fructus schisandrae chinensis are decocted together in water; water extract or eluate is precipitated with alcohol or acetone, treated with macroporous adsorption resin and with ion exchange resin, and then separated to obtain pharmaceutical composition containing effective fractions of polysacchrides, saponins and amino acids. The above mentioned pharmaceutical composition can be formed into various preparations by mixing with any pharmaceutically acceptable auxiliary materials.Type: GrantFiled: December 19, 2001Date of Patent: July 22, 2003Assignees: China Pharmaceutical University, Ningbo Asia-Pacific Biotechnology Ltd.Inventors: Yongqing Yan, Minghui Tang, Danni Zhu, Shufei Zhuang
-
Patent number: 6589572Abstract: A composition for treating hypertension and lowering cholesterol is provided which contains the mixed extract of Panax notoginseng and Salvia miltiorrhiza as an active ingredient thus lowering and maintaining blood pressure substantially constant. Also provided is a method for preparing composition containing the mixed extract of Panax notoginseng and Salvia miltiorrhiza as an active ingredient.Type: GrantFiled: June 14, 2001Date of Patent: July 8, 2003Assignee: Medvill Co., Ltd.Inventors: Eun Kyung Hong, Young Shin Chung
-
Publication number: 20030124207Abstract: This invention is directed towards processes of making fractions from North American ginseng and to compositions containing these fractions. This invention is also directed towards methods of methods of preparing pharmaceuticals containing these fractions. Additionally, this invention is directed towards methods of stimulating the production of immunoglobins by administering fractions of this invention and also to methods of activating B-lymphocyte proliferation and antibody production by administering fractions of this invention. This invention is also directed towards a method of stimulating the production of IL-16, IL-1, and/or TNF-&agr; in cells by administering a fraction of this invention.Type: ApplicationFiled: July 2, 2002Publication date: July 3, 2003Inventors: Jacqueline J. Shan, Peter K. T. Pang, Buhan Huang, Lei Ling
-
Publication number: 20030124206Abstract: The present invention provides an herbal pharmaceutical compositions comprising the root of scutellaria, the rhizome of coptis, the root and rhizome of rhubarb, and the dry powders of the root of ginseng (or American ginseng) or the rhizome of ginger. The herbal pharmaceutical compositions are effective in preventing patients from developing or treating patients with cardiovascular diseases, which include, but are not limited to, hypertension, coronary heart disease, cerebrovascular disease, peripheral vascular disease, heart failure, rheumatic heart disease, congenital heart disease, and cardiomyopathies. The present invention also provides methods for preparing and using the herbal pharmaceutical compositions.Type: ApplicationFiled: June 10, 2002Publication date: July 3, 2003Inventors: Shuenn-Jyi Sheu, Chung Guang Shen
-
Patent number: 6586017Abstract: A composition comprising Denhichi, Tochu and Osei, wherein the Denhichi is Panax pseudo-ginseng, the Tochu is Eucommiae ulmoides and the Osei is selected from the group consisting of Polygonati Rhizoma, Polygonatum falcatum, other plants belonging to the genus Polygonatum, and Siberian Solomonseal Rhizome.Type: GrantFiled: March 9, 2001Date of Patent: July 1, 2003Inventors: Shinhan Sha, Noboru Yanaihara
-
Publication number: 20030118661Abstract: This invention opens a prescription of a pure biological life-prolong product. The product is made from the following ingredients in weight proportion: soft-shelled turtle 100, ageratum 2-5, ginseng 2-5, and glucose 2-5. Every ingredient is ground into powder and mixed together in proportion; then add an appropriate amount of water, boil by slow fire and filtrate into aqua form, or dry the filtrate and extract into powder form, bolus form or tablet form. This medicine can improve human immune functions, accelerate human metabolism by the increase of cell division and cell regeneration so as to reach the goal of cancer prevention and treatment, youth keeping and life prolong.Type: ApplicationFiled: July 11, 2002Publication date: June 26, 2003Inventor: Yongzhong Li
-
Patent number: 6579543Abstract: A composition for topical application to an animal's skin for relief from a variety of symptoms caused by medical conditions or physical injuries. The composition includes at least one compound having analgesic activity, at least one compound having anti-inflammatory activity, at least one compound having antioxidant activity, at least one compound having anti-neuralgic activity, at least one compound having blood circulation promotion activity, and at least one compound having antidepressant activity. A method for relieving pain by topical application of the composition is also provided.Type: GrantFiled: May 21, 2002Date of Patent: June 17, 2003Inventor: Jackie H. McClung